Wheeler, Mark D <br/><br/>
A 26-week, randomized trial of insulin detemir versus NPH insulin in children and adolescents with type 2 diabetes (iDEAt2).  [electronic resource] 

 -  European journal of pediatrics  Oct 2018 
 - 1497-1503 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1432-1076 
<br/><br/><label>Standard No.: </label>10.1007/s00431-018-3205-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Blood Glucose--drug effects<br/>Child<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Female<br/>Glycated Hemoglobin--drug effects<br/>Humans<br/>Hypoglycemic Agents--adverse effects<br/>Insulin Detemir--adverse effects<br/>Insulin, Isophane--adverse effects<br/>Life Style<br/>Male<br/>Metformin--therapeutic use